Immunotoxicity encompasses both reduced and heightened immune function. Diverse chemicals can impair functioning of the immune system. Both monographs and books have been devoted to detailed descriptions of immunotoxicity. This paper gives a brief overview of the methods currently used to assess the immunotoxic potential of chemicals. It also discusses the trend toward the use of alternative methods to mammalian models, such as feral species, in vitro assays, and computational models. The strategy of using a tier approach to screen chemicals for immunotoxicity is described, together with the rationale for, and limitations of, this approach. Interpretation of data with regard to clinical disease and human health is addressed. The immune system poses substantial complexities in this regard as the system has functional reserve and functional redundancy. Environ Health Perspect 1 06(Suppl 2):533-540 (1998). http://ehpnetl. niehs.nih.gov/docs/1998/Suppl-2/533-540karoI/abstract.html
Introduction
The immune system is a complex, multicomponent system that comprises lymphoid organs located throughout the body and interacting, specialized cells. The major lymphoid organs are the spleen, thymus, lymph nodes, bone marrow, and areas of the intestine (Peyer's patches). The major cell type is the lymphocyte; accessory cells include macrophages, natural killer (NK) cells, eosinophils, basophils, dendritic cells, and epithelial cells, among others.
The immune system functions to protect against both the external environment and the internal development of nonself neoplasms. A branch of immunology designated tumor immunology is devoted to the study of the immune responses acquired to tumor antigens and the nature of the antigens on tumor cells that induce the immune responses. Dysfunction of the immune system results in increased incidence and severity of infection, increased reactivity toward environmental agents (hypersensitivity), and increased development of tumors.
The organs, tissues, cells, and molecules of the immune system interact to provide a coordinated immune response. Lymphocytes circulate among lymphoid organs throughout the body. Through surface receptors, they recognize three-dimensional molecular configurations. Upon engagement of surface molecules with structures having complementary conformation, lymphocytes become activated. They proliferate, yielding generations of cells capable of recognizing and responding to the same antigen upon future encounter (1) .
The two main populations of lymphocytes are B lymphocytes and T lymphocytes. Both types of cells function through 
Cell-Mediated Immune System
Cell-mediated immunity is assessed by measurement of the blastogenesis and proliferation of lymphocyte populations when stimulated with nonspecific mitogens (7). The HR assays allow detection of the interactive function of key immune components, including T and B lymphocytes, macrophages, and the complement system (12) . For example, resistance to intracellular microorganisms requires induction of CMI through T lymphocyte-macrophage interaction, production of cytokines, and bactericidal activity of macrophages. Resistance to transplantable tumors is dependent on T cell function and natural cytotoxicity.
Predictive Value of Tier Tests
A study was performed to evaluate each of the tests, and combinations of tests, in the tier battery for immunotoxicity (Table 1) for its ability to predict immunosuppression (6) . The database for this analysis consisted of over 50 chemicals that had been tested by the National Institute of Environmental Health Sciences, the Chemical Industry Institute of Toxicology, and the U.S. National Toxicology Program. Individually, two tests were able to predict immunotoxicity in rodents. The test that had the greatest predictive power was enumeration of the lymphocyte populations (based on cell-surface markers, 83% correct predictions), followed by the PFC assay (78% correct). The sensitivity of these tests may be a result of relying on multiple immune processes. The remaining tests in the battery were not good predictors of immunotoxicity.
Combinations of tests were examined to determine their ability to identify immunotoxic chemicals (6) . The combination of the PFC response, or lymphocyte surface marker determination, with almost any other assay increased the ability to detect immunotoxicity to greater than 90%. The combination of PFC and surface markers gave 91% accurate prediction. DTH alone had poor predictability, but when coupled with almost any other test, yielded high predictivity. This suggests that DTH has little functional interdependence with the other tests in the battery (6) . The findings of the study suggest that some tests could be deleted from the battery of assays without significantly decreasing the likelihood of identifying a potential immunotoxicant.
A major issue that remains in the use of these tests is that of immune system reserve. Further information is needed about the relationship between qualitative and quantitative changes in immune tests and development of clinical disease. The threshold level in each test must be addressed in considering whether functional changes imply clinical disease.
Nonhuman Primates
Immunotoxicity tests have been performed using several nonhuman primates including rhesus macaques, cynomologous monkeys, and marmosets. Most of the assays involve blood or serum. In some models, monoclonal antibodies to human leukocytes can be used (13) . Additionally, assessment of DTH lymphocyte proliferation to mitogens, NK function, and cytokine production have been used to assess effects of chronic exposure to Arochlor 1254 (13) . It is expected that use of these models will increase with the availability of further biotechnology products. 
Immunotoxicity Assessment in Humans

Respiratory Hypersensitivity
Respiratory hypersensitivity is diagnosed in humans by a decrease in FEV1 after exposure to the agent (14) . For proteins and other high molecular weight materials, the response is believed to be of immunologic origin; for low molecular weight materials such as industrial chemicals the mechanism remains unclear (14) .
Mechanistically, responsiveness to high molecular mass allergens is usually attributed to allergen-specific IgE. Animal models have been developed to better understand the pathogenesis of the disorder and to compare potencies of test agents, largely proteins. As reviewed by the author (22) , a variety of species has been utilized including mice, rats, guinea pigs, rabbits, dogs, sheep, horses, and nonhuman primates. Differences among the models indude animal species utilized, route of administration of the agent, protocol for induction and elicitation of responses, type of response measured, and judgment of a significant response.
Low molecular weight (LMW) allergens (< 1 kDa) are considered too small to stimulate an immune response, but are capable of this activity when chemically associated with a large molecule, such as serum albumin, as a hapten (14) . Models of respiratory sensitization by LMW agents include the guinea pig, mouse and rat models, and the mouse IgE model (22) . Guinea Pig Model Guinea pigs have been the species of choice for predictive models of respiratory hypersensitivity. The inhalation model (23) and the intratracheal model (24) rely on the physiologic respiratory response of animals to challenge with the sensitizing agent, as well as on the production of allergic antibody. These models have been calibrated to human sensitization through the use of detergent enzyme allergens, for which there are good human exposure and response data (24) .
Guinea pig methods for measurement of chemical-induced respiratory allergy also rely upon the inhalation route for both the induction and elicitation phases of reaction. Elicitation of the response to respiratory challenge is performed with the chemical, or with a protein conjugate of the chemical (23) . Less emphasis is placed on the production of allergic antibody, as few chemicals induce such antibodies in humans, and it is uncertain if antibodies have a role in the sensitization response.
The inhalation model was developed for use with toluene diisocyanate (25) , and has been applied successfully to the study of other isocyanates and some acid anhydrides. It was not able to detect sensitization to some reactive dyes (23), although allergic antibody was produced to the latter.
Drawbacks of the guinea pig models include the cost of the studies and the technical expertise required to generate and monitor atmospheres of reactive chemical sensitizers and to monitor respiratory responses in challenged animals. These methods were developed Environmental Health Perspectives a Vol 106, Supplement 2 * April 1998 mainly for investigational purposes and not for routine screening.
Mouse Model
A mouse model has been described to assess the relative allergenicity of proteins and polypeptides (26) . The benchmark allergen used to compare responses is the protease, subtilisin. Intranasal and intratracheal dosing have been used. Specific antibodies are measured as a function of the dose of antigen administered, the dosing matrix, and the isotype of antibody produced. Using subtilisin, peak antibody responses were observed after 6 to 8 weeks of dosing. Detergent administered with the allergen augmented the TgG 1 responses approximately 4-fold. IgE responses were inconsistent. Differences in potencies of proteins paralleled findings with the guinea pig model. Compared with the guinea pig method, the murine system has the advantage of lower cost, easier handling, and need for less material.
Mouse IgE Test. The primary reason for development of the assay was for predictive purposes, rather than for mechanistic studies (27) . The method is based on the assumption that respiratory allergens stimulate a Th2 lymphocyte response in mice, whereas contact allergens would provoke a Th, response. Th, cells secrete IL-2 and interferon y, whereas Th2 cells secrete IL-4 and IL-10. The latter cytokines stimulate production of IgE.
The assay is performed by repeatedly exposing mice epicutaneously to the chemical; usually three concentrations are used. After an interval of several weeks, serum is taken for evaluation of IgE and cytokines.
This method remains to be validated by independent laboratories. Potential advantages of the method are cost and speed. Because Animal models have been described for experimental induction of autoimmune disease (29) . However, these models are used mainly to elucidate the pathogenesis of autoimmunity rather than for toxicologic assessment.
There are several mechanisms associated with autoimmunity (29) . Release of antigens that are normally segregated from the immune system, for example, the lens of the eye, can initiate the process. A second mechanism relies on molecular mimicry. This process is based on the observation that antigenic determinants in the body are often replicated on foreign antigens. Beta hemolytic streptococci possess membrane determinants that resemble antigens of the cardiac myocyte. Molecular mimicry may also occur when changes are induced on endogenous antigens. Altered self-molecules are partially foreign and may be recognized as foreign by the immune system. Viruses may attack the reticuloendothelial system and alter immune recognition or regulation of cell populations. It must be emphasized, however, that although autoantibodies may be produced, they do not imply disease (29) .
Risk Assessment
The guinea pig intratracheal model has been used for assessment of risk for respiratory hypersensitivity from protein allergens (30 (33) . For contact sensitivity, several SAR models have accurately predicted strong-moderate sensitizers by identifying electrophiles, nucleophiles, proelectrophiles, and pronucleophiles (34) . The CASE/MultiCASE artificial intelligence system has moderate success in identifying weak sensitizers (34) . This latter system differs from others in that it does not assume a mechanism of sensitization, but rather operates from identification of structural fragments that have a statistical association with the dass of sensitizing chemicals as compared with non-sensitizing chemicals.
An SAR model for respiratory chemical sensitizers has been described (2, 33 
Validation
There must be validation of the tests that evaluate immunotoxicity. The goal of validation is to determine which methods should be recommended in the testing guidelines of regulatory agencies. Validation consists of testing a set of compounds with known positive and negative immunotoxicity and determining the sensitivity, specificity, accuracy, and precision of the tests (13) . These parameters are defined as sensitivity, the ability to identify positive chemicals; specificity, the ability to identify negative chemicals; accuracy, the ability to measure the intended end point; and precision, the ability to reproduce results. Some test methods have undergone validation as described in previous sections ("Predictive Value ofTier Tests" and "Risk Assessment"). However, consideration must be given to the question ofwhether validation requires compounds to be shown to be immunosuppressive in humans as well as in rodents.
Conclusions
Trends are emerging among the newer methods being developed for immunotoxicity testing. Prominent 
